Law360, New York (November 10, 2008) -- The city of Baltimore has launched a class action on behalf of Maryland governmental entities accusing McKesson Corp. of scheming to raise and fix pharmaceutical drug prices, costing the plaintiffs millions of dollars in inflated reimbursements.
The Maryland government entities, which sued on Friday in the U.S. District Court of Massachusetts, followed lawsuits by San Francisco, Oklahoma and Connecticut and several class actions by private consumers,...
